Torrent Pharma Allots 4.19 Crore Shares After JB Chemicals Merger

Mumbai, July 21: Torrent Pharmaceuticals Ltd has allotted 4,19,22,416 fully paid-up equity shares to eligible shareholders of J. B. Chemicals & Pharmaceuticals Limited under their Scheme of Amalgamation. The company’s committee approved the allotment on July 20, while TORNTPHARM trades at ₹5,014.50, up 0.18% so far today as of 12:15 PM on July 21, 2026. 

Key takeaways 

• Allotment: Torrent Pharma allotted 4,19,22,416 equity shares with a face value of ₹5 each.
• Exchange ratio: Eligible JB Chemicals shareholders received 51 Torrent Pharma shares for every 100 shares held.
• Intraday move: TORNTPHARM is trading 0.18% higher so far today.
• Capital base: Paid-up equity capital increased from ₹169.22 crore to ₹190.18 crore.
• 52-week position: The stock is in the upper third of its 52-week range, closer to the high than the low.

The share count rises under the approved scheme 

The allotment was made to eligible JB Chemicals shareholders on the basis of the July 17 record date. Each allotted Torrent Pharma share has a face value of ₹5, and the exchange ratio specified under the scheme is 51 Torrent Pharma shares for every 100 JB Chemicals shares. 

The transaction increased Torrent Pharma’s issued and paid-up share count from 33,84,45,440 shares to 38,03,67,856 shares. The amalgamation scheme had been sanctioned by the Ahmedabad Bench of the National Company Law Tribunal on July 6. 

In practical terms, the allotment expands the company’s equity capital and shareholder base following the amalgamation. The larger number of outstanding shares may affect shareholding patterns, making the post-allotment ownership structure a relevant consideration. 

What does a 0.18% midday move show against pharma peers? 

The stock opened at ₹4,978.40 and has moved between an intraday low of ₹4,948 and a high of ₹5,030.80. That represents a trading band of about 1.7% so far today. 

About 1.57 lakh shares have changed hands so far, compared with a full-day average of about 7.35 lakh shares. Since the session remains in progress, the intraday total is not directly comparable with a completed trading day’s activity. 

The stock is in the upper third of its 52-week range, closer to the high than the low. Its current price is about 1% below the 52-week high of ₹5,085.80, while the 52-week low stands at ₹3,468. 

The broader market is softer while pharmaceutical shares are marginally positive: NIFTY 50 edged lower -0.25%, while NIFTY PHARMA edged higher +0.12%. Among peers, SUNPHARMA +0.29%, DIVISLAB -0.11%, CIPLA -0.56%, LUPIN +1.36%, ZYDUSLIFE -0.39%. 

Separately, Indiatimes reported on July 20 that Tatva Chintan Pharma Chem approved a ₹200 crore greenfield expansion at Dahej-III, targeting 344 KL of reactor capacity, and that its board sought to raise the borrowing limit to ₹1,000 crore. That development is sector context and is not a Torrent Pharmaceuticals-specific trigger. 

₹1.70 lakh crore scale and TTM valuation after the allotment 

Torrent Pharmaceuticals has a market capitalisation of ₹1.70 lakh crore. It trades at a trailing-twelve-month PE of 79.24, with trailing-twelve-month EPS of ₹63.92. 

For the rest of the July 21 session, the immediate monitorables are trading around the stock’s intraday band and activity as the volume total builds. Beyond today’s trade, the completed share allotment and the resulting changes in Torrent Pharma’s equity base remain the concrete outcomes of the amalgamation to track. 

Frequently asked questions 

What shares did Torrent Pharma allot under the JB Chemicals amalgamation? 

Torrent Pharmaceuticals allotted 4,19,22,416 fully paid-up equity shares with a face value of ₹5 each to eligible JB Chemicals shareholders. The July 20, 2026 allotment followed an exchange ratio of 51 Torrent Pharma shares for every 100 JB Chemicals shares. 

How is TORNTPHARM trading on July 21, 2026? 

TORNTPHARM is trading at ₹5,014.50, up 0.18% so far on July 21, 2026. The stock has traded between ₹4,948 and ₹5,030.80 during the session. 

How did the allotment change Torrent Pharma’s equity capital? 

The allotment increased Torrent Pharmaceuticals’ issued and paid-up share count from 33,84,45,440 to 38,03,67,856 shares. Paid-up equity capital rose from ₹169.22 crore to ₹190.18 crore. 

Where does Torrent Pharma stand relative to its 52-week range? 

On July 21, 2026, Torrent Pharma is in the upper third of its 52-week range, closer to the high than the low. At ₹5,014.50, it is about 1% below its 52-week high of ₹5,085.80. 

Source Links 

• https://www.nseindia.com/get-quotes/equity?symbol=TORNTPHARM
• http://chemicals.economictimes.indiatimes.com/news/industry-and-market/tatva-chintan-pharma-chem-sets-sights-on-200-crore-greenfield-expansion-to-meet-surging-demand/132513859
• https://nsearchives.nseindia.com/corporate/TORNTPHARM_20072026124412_SE_Intimation_Allotment_of_shares.pdf